Judith Dunn
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Judith A. Dunn is Director at BioIVT LLC since 2024.
Independent Non-Executive Director at Evolution Research Group LLC since 2018.
Independent Director at Climb Bio, Inc. since 2021.
Director at The Partnership Fund For New York City.
Head-Research & Development at Vima (Texas) since 2023.
Formerly Chairman at New York Biotechnology Association, Inc. from 2016 to 2018.
Executive Medical Director at Sumitomo Pharma America, Inc. from 2005 to 2010.
Independent Director at Seelos Therapeutics, Inc. from 2020 to 2021.
Vice President-Research & Development at F.
Hoffmann-La Roche Ltd. from 2014 to 2018.
President & Head-Research & Development at Fulcrum Therapeutics, Inc. from 2021 to 2023.
Educated at Rochester Christian University (undergraduate) and Wesleyan University (doctorate).
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CLIMB BIO, INC. -.--% | 05.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CLIMB BIO, INC. | Direktor/Vorstandsmitglied | 01.02.2021 |
Evolution Research Group LLC
Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Direktor/Vorstandsmitglied | 01.08.2018 |
BioIVT LLC
BioIVT LLC Medical/Nursing ServicesHealth Services Provides bio specimen and research services to the life science & diagnostic industries | Direktor/Vorstandsmitglied | 01.01.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| SEELOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.09.2021 |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Vorsitzender | 01.06.2018 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 01.01.2010 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
BioIVT LLC
BioIVT LLC Medical/Nursing ServicesHealth Services Provides bio specimen and research services to the life science & diagnostic industries | Health Services |
Evolution Research Group LLC
Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Seelos Therapeutics, Inc.
Seelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for neurological disorders and rare diseases using pipeline targeting CNS conditions | Health Technology |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen